Cytokine gene variation is associated with depressive symptom trajectories in oncology patients and family caregivers

European Journal of Oncology Nursing

Volumn 17, Issue 3, 2013, Pages 346-353

  Dunn, Laura B ^a   Aouizerat, Bradley E ^b   Langford, Dale J ^b   Cooper, Bruce A ^b   Dhruva, Anand ^a   Cataldo, Janine K ^b   Baggott, Christina R ^b   Merriman, John D ^b   Dodd, Marylin ^b   West, Claudia ^b   Paul, Steven M ^b   Miaskowski, Christine ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Cytokines; Depression; Family caregivers; Genetics; Growth mixture modeling; Radiation therapy

Indexed keywords

CYTOKINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAREGIVER; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; DEPRESSION; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; ONCOLOGY; PHENOTYPE; PSYCHOLOGICAL ASPECT; SEVERITY OF ILLNESS INDEX; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; CALIFORNIA; CAREGIVERS; COHORT STUDIES; COMORBIDITY; CYTOKINES; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 84876314568     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2012.10.004     Document Type: Article

References (81)

1. Aouizerat B.E., Dodd M., Lee K., West C., Paul S.M., Cooper B.A., et al. Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biological Research for Nursing 2009, 11:27-41.
2. Bardwell W.A., Natarajan L., Dimsdale J.E., Rock C.L., Mortimer J.E., Hollenbach K., et al. Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. Journal of Clinical Oncology 2006, 24:2420-2427.
3. Capuron L., Gumnick J.F., Musselman D.L., Lawson D.H., Reemsnyder A., Nemeroff C.B., et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002, 26:643-652.
4. Carter P.A., Acton G.J. Personality and coping: predictors of depression and sleep problems among caregivers of individuals who have cancer. Journal of Gerontological Nursing 2006, 32:45-53.
5. Cerri A.P., Arosio B., Viazzoli C., Confalonieri R., Vergani C., Annoni G. The -308 (G/A) single nucleotide polymorphism in the TNF-alpha gene and the risk of major depression in the elderly. International Journal of Geriatric Psychiatry 2010, 25:219-223.
6. Chachamovich E., Fleck M., Laidlaw K., Power M. Impact of major depression and subsyndromal symptoms on quality of life and attitudes toward aging in an international sample of older adults. Gerontologist 2008, 48:593-602.
7. Chen L., Eaton W.W., Gallo J.J., Nestadt G. Understanding the heterogeneity of depression through the triad of symptoms, course and risk factors: a longitudinal, population-based study. Journal of Affective Disorders 2000, 59:1-11.
8. Collado-Hidalgo A., Bower J.E., Ganz P.A., Irwin M.R., Cole S.W. Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings. Brain Behavior and Immunity 2008, 22:1197-1200.
9. Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993, 261:472-475.
10. Conde L., Vaquerizas J.M., Dopazo H., Arbiza L., Reumers J., Rousseau F., et al. PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Research 2006, 34:W621-W625.
11. Couper J., Bloch S., Love A., Macvean M., Duchesne G.M., Kissane D. Psychosocial adjustment of female partners of men with prostate cancer: a review of the literature. Psychooncology 2006, 15:937-953.
12. Couper J.W., Bloch S., Love A., Duchesne G., Macvean M., Kissane D.W. The psychosocial impact of prostate cancer on patients and their partners. Medical Journal of Australia 2006, 185:428-432.
13. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behavior and Immunity 2007, 21:153-160.
14. Dantzer R., Capuron L., Irwin M.R., Miller A.H., Ollat H., Perry V.H., et al. Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology 2008, 33:18-29.
15. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 2008, 9:46-56.
16. Deimling G.T., Bowman K.F., Sterns S., Wagner L.J., Kahana B. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology 2006, 15:306-320.
17. Deshields T., Tibbs T., Fan M.Y., Taylor M. Differences in patterns of depression after treatment for breast cancer. Psychooncology 2006, 15:398-406.
18. Donovan K.A., Small B.J., Andrykowski M.A., Munster P., Jacobsen P.B. Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment. Health Psychology 2007, 26:464-472.
19. Dunn L.B., Cooper B.A., Neuhaus J., West C., Paul S., Aouizerat B., et al. Identification of distinct depressive symptom trajectories in women following surgery for breast cancer. Health Psychology 2011, 30:683-692.
20. Dunn L.B., Aouizerat B.E., Cooper B.A., Dodd M., Lee K., West C., et al. Trajectories of anxiety in oncology patients and family caregivers during and after radiation therapy. European Journal of Oncology Nursing 2012, 16:1-9.
21. Feder A., Nestler E.J., Charney D.S. Psychobiology and molecular genetics of resilience. Nature Review Neuroscience 2009, 10:446-457.
22. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
23. Given B., Given C.W., Sikorskii A., Jeon S., McCorkle R., Champion V., et al. Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points?. Journal of Pain and Symptom Management 2008, 35:126-135.
24. Gottlieb B.H., Rooney J.A. Coping effectiveness: determinants and relevance to the mental health and affect of family caregivers of persons with dementia. Aging and Mental Health 2004, 8:364-373.
25. Gur A., Sarac A.J., Burkan Y.K., Nas K., Cevik R. Arthropathy, quality of life, depression, and anxiety in Behcet's disease: relationship between arthritis and these factors. Clinical Rheumatology 2006, 25:524-531.
26. Halder I., Shriver M., Thomas M., Fernandez J.R., Frudakis T. A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: utility and applications. Human Mutation 2008, 29:648-658.
27. Haroon E., Raison C.L., Miller A.H. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012, 37:137-162.
28. Helgeson V.S., Snyder P., Seltman H. Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychology 2004, 23:3-15.
29. Henselmans I., Helgeson V.S., Seltman H., de Vries J., Sanderman R., Ranchor A.V. Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis. Health Psychology 2010, 29:160-168.
30. Hoggart C.J., Parra E.J., Shriver M.D., Bonilla C., Kittles R.A., Clayton D.G., et al. Control of confounding of genetic associations in stratified populations. American Journal of Human Genetics 2003, 72:1492-1504.
31. Hooker K., Monahan D.J., Bowman S.R., Frazier L.D., Shifren K. Personality counts for a lot: predictors of mental and physical health of spouse caregivers in two disease groups. Journals of Gerontology Series B, Psychological Sciences and Social Sciences 1998, 53:P73-P85.
32. Hou W.K., Law C.C., Yin J., Fu Y.T. Resource loss, resource gain, and psychological resilience and dysfunction following cancer diagnosis: a growth mixture modeling approach. Health Psychology 2010, 29:484-495.
33. Institute of Medicine Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs 2007, The National Academies Press, Washington, DC.
34. Jung T., Wickrama K.A.S. An introduction to latent class growth analysis and growth mixture modeling. Social and Personality Psychology Compass 2008, 2:302-317.
35. Karnofsky D., Abelmann W.H., Craver L.V., Burchenal J.H. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948, 1:634-656.
36. Kim Y., Given B.A. Quality of life of family caregivers of cancer survivors: across the trajectory of the illness. Cancer 2008, 112:2556-2568.
37. Kim Y., Duberstein P.R., Sorensen S., Larson M.R. Levels of depressive symptoms in spouses of people with lung cancer: effects of personality, social support, and caregiving burden. Psychosomatics 2005, 46:123-130.
38. Kim Y., Carver C.S., Deci E.L., Kasser T. Adult attachment and psychological well-being in cancer caregivers: the mediational role of spouses' motives for caregiving. Health Psychology 2008, 27:S144-S154.
39. Kornblith A.B., Powell M., Regan M.M., Bennett S., Krasner C., Moy B., et al. Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology 2007, 16:895-903.
40. Kurtz M.E., Kurtz J.C., Given C.W., Given B. Predictors of postbereavement depressive symptomatology among family caregivers of cancer patients. Supportive Care in Cancer 1997, 5:53-60.
41. Kurtz M.E., Kurtz J.C., Given C.W., Given B.A. Depression and physical health among family caregivers of geriatric patients with cancer - a longitudinal view. Medical Science Monitoring 2004, 10:CR447-456.
42. Lam W.W., Bonanno G.A., Mancini A.D., Ho S., Chan M., Hung W.K., et al. Trajectories of psychological distress among Chinese women diagnosed with breast cancer. Psychooncology 2010, 19:1044-1051.
43. Lam W.W., Shing Y.T., Bonanno G.A., Mancini A.D., Fielding R. Distress trajectories at the first year diagnosis of breast cancer in relation to 6 years survivorship. Psychooncology 2012 Jan, 21(1):90-99.
44. Lee Y.H., Ji J.D., Song G.G. Tumor necrosis factor-alpha promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. Journal of Rheumatology 2007, 34:43-49.
45. Legler J.M., Davis W.W., Potosky A.L., Hoffman R.M. Latent variable modelling of recovery trajectories: sexual function following radical prostatectomy. Statistics in Medicine 2004, 23:2875-2893.
46. Levinson D.F. The genetics of depression: a review. Biological Psychiatry 2006, 60:84-92.
47. Lyness J.M., Kim J., Tang W., Tu X., Conwell Y., King D.A., et al. The clinical significance of subsyndromal depression in older primary care patients. American Journal of Geriatric Psychiatry 2007, 15:214-223.
48. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997, 9:853-858.
49. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metabolic Brain Disease 2009, 24:27-53.
50. Massie M.J. Prevalence of depression in patients with cancer. Journal of the National Cancer Institute Monographs 2004, 32:57-71.
51. Miaskowski C., Dodd M., Lee K., West C., Paul S.M., Cooper B.A., et al. Preliminary evidence of an association between a functional interleukin-6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers. Journal of Pain and Symptom Management 2010, 40:531-544.
52. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 2009, 65:732-741.
53. Muthen B.O., Kaplan D.W. Latent variable analysis: growth mixture modeling and related techniques for longitudinal data. The Sage Handbook of Quantitative Methodology for the Social Sciences 2004, 345-368. Sage Publications, Newbury Park, CA. D. Kaplan (Ed.).
54. Muthen L.K., Muthen B.O. Mplus User's Guide 1998-2010, Muthen & Muthen, Los Angeles, CA. sixth ed.
55. Muthen B., Muthen L.K. Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes. Alcoholism, Clinical and Experimental Research 2000, 24:882-891.
56. Myint A.M., O'Mahony S., Kubera M., Kim Y.K., Kenny C., Kaim-Basta A., et al. Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats. Journal of Psychopharmacology 2007, 21:843-850.
57. Nylund K.L., Asparouhov T., Muthen B.O. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Structural Equation Modeling 2007, 14:535-569.
58. Pearlin L.I., Mullan J.T., Semple S.J., Skaff M.M. Caregiving and the stress process: an overview of concepts and their measures. Gerontologist 1990, 30:583-594.
59. Perkins E.A., Small B.J., Balducci L., Extermann M., Robb C., Haley W.E. Individual differences in well-being in older breast cancer survivors. Critical Review of Oncology and Hematology 2007, 62:74-83.
60. Pirl W.F. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. Journal of the National Cancer Institute Monographs 2004, 32:32-39.
61. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nature Genetics 2006, 38:904-909.
62. Rabin E.G., Heldt E., Hirakata V.N., Fleck M.P. Quality of life predictors in breast cancer women. European Journal of Oncology Nursing 2008, 12:53-57.
63. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977, 1:385-401.
64. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 2006, 27:24-31.
65. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., et al. Cytokine-associated emotional and cognitive disturbances in humans. Archives of General Psychiatry 2001, 58:445-452.
66. Remmers E.F., Cosan F., Kirino Y., Ombrello M.J., Abaci N., Satorius C., et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nature Genetics 2010, 42:698-702.
67. Rhee Y.S., Yun Y.H., Park S., Shin D.O., Lee K.M., Yoo H.J., et al. Depression in family caregivers of cancer patients: the feeling of burden as a predictor of depression. Journal of Clinical Oncology 2008, 26:5890-5895.
68. Rose J.H., Kypriotakis G., Bowman K.F., Einstadter D., O'Toole E.E., Mechekano R., et al. Patterns of adaptation in patients living long term with advanced cancer. Cancer 2009, 115:4298-4310.
69. Satin J.R., Linden W., Phillips M.J. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 2009, 115:5349-5361.
70. Schou I., Ekeberg O., Ruland C.M., Sandvik L., Karesen R. Pessimism as a predictor of emotional morbidity one year following breast cancer surgery. Psychooncology 2004, 13:309-320.
71. Seruga B., Zhang H., Bernstein L.J., Tannock I.F. Cytokines and their relationship to the symptoms and outcome of cancer. Nature Review Cancer 2008, 8:887-899.
72. Spielberger C. Manual for the State-trait Anxiety Inventory (Form Y) 1983, Consulting Psychologists Press, Palo Alto, CA.
73. SPSS IBM SPSS for Windows (Version 19) 2010, SPSS, Inc, Chicago, Illinois.
74. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics 2001, 68:978-989.
75. Taylor D.H., Ezell M., Kuchibhatla M., Ostbye T., Clipp E.C. Identifying trajectories of depressive symptoms for women caring for their husbands with dementia. Journal of American Geriatrics Society 2008, 56:322-327.
76. Tian C., Gregersen P.K., Seldin M.F. Accounting for ancestry: population substructure and genome-wide association studies. Human Molecular Genetics 2008, 17:R143-R150.
77. Tofighi D., Enders C.K. Identifying the correct number of classes in growth mixture models. Advances in Latent Variable Mixture Models 2008, 317-341. Information Age Publishing, Charlotte, NC. G.R. Hancock, S.M. Samuelsen (Eds.).
78. Williams J.W., Kerber C.A., Mulrow C.D., Medina A., Aguilar C. Depressive disorders in primary care: prevalence, functional disability, and identification. Journal of General Internal Medicine 1995, 10:7-12.
79. Yabroff K.R., Kim Y. Time costs associated with informal caregiving for cancer survivors. Cancer 2009, 115:4362-4373.
80. Zhu C.B., Blakely R.D., Hewlett W.A. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 2006, 31:2121-2131.
81. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behavior and Immunity 2001, 15:199-226.